Oncomatryx logo

Oncomatryx

Developer of ADCs to treat metastatic solid tumors.

2

Funding Rounds

$21.3m

Money raised

Overview

Developer of ADCs to treat metastatic solid tumors.

Funding series

Funding Series Analysis

The company Oncomatryx has raised a total of $16m in funding over 2 rounds.

Key Insights:

  • Oncomatryx April 2022 Funding Round: $16m
  • Oncomatryx, Venture Round, December 2015: $5.3m
Oncomatryx logo
Oncomatryx April 2022 Funding Round $16m
Oncomatryx logo
Oncomatryx, Venture Round, December 2015 $5.3m